MyChesCo on MSN4d
FDA Grants Fast Track Designation to PleoPharma’s PP-01 for Cannabis Withdrawal Syndrome
PleoPharma, Inc. has announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to PP-01, ...
The Lancet5d
Management of alcohol use disorder: a gastroenterology and hepatology-focused perspective
Alcohol use disorder is a prevalent and major but preventable cause of morbidity and mortality worldwide, causing several ...